Anaplastic Thyroid Carcinoma

Anaplastic thyroid carcinoma, also known as undifferentiated thyroid carcinoma, is a rare, highly aggressive malignant tumor accounting for 2 to 3 percent of all thyroid gland neoplasms. Anaplastic thyroid carcinoma continues to be one of the most deadly diseases worldwide and carries a very poor prognosis.

02xl is your source for accurate and trustworthy information so you can make the best choices for your health and wellness.

PS: Please note that 02xl provides this information for the benefit of the rare disease and overweight community. 02xl is not a medical provider or health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.

Response to Larotrectinib in NTRK+ Thyroid Cancer Differs By Subtype

Lori J. Wirth, MD, associate professor of medicine at Harvard Medical School and medical director of the Center for Head…

Lori J. Wirth, MD Lori J. Wirth, MD

Genetic alterations in thyroid cancer mediate resistance to BRAF inhibition and anaplastic transformation

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring…

02xl Admin 02xl Admin

Triple Therapy Boosts Anaplastic Thyroid Cancer Survival

WASHINGTON ― Adding the PD-1 inhibitor pembrolizumab to the established combination of dabrafenib and trametinib (DT) significantly improves survival outcomes…

Nancy A. Melville Nancy A. Melville
- Advertisement -
Ad imageAd image
Latest Anaplastic Thyroid Carcinoma News

dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

Identification of PIAS2b as a target protein in thyroid cancerUsing h7H culture…

Miguel Chenlo Miguel Chenlo

A Comprehensive Study Exploring Anaplastic Thyroid Cancer

Anaplastic Thyroid Cancer Treatment MarketAdvance Market Analytics published a new research publication…

Understanding Mutations and Targeted Treatments in Thyroid Cancer

3D illustration of thyroid gland: © Anatomy Insider - stock.adobe.comWhile BRAF mutations…

Sabrina Serani Sabrina Serani

Response to Larotrectinib in NTRK+ Thyroid Cancer Differs By Subtype

Lori J. Wirth, MD, associate professor of medicine at Harvard Medical School…

Lori J. Wirth, MD Lori J. Wirth, MD

A Look at the Latest Advancements in Thyroid Cancer Treatment

Lori J. Wirth, MD, associate professor of medicine at Harvard Medical School…

Lori J. Wirth, MD Lori J. Wirth, MD

Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission

Drugs and reagentsRuxolitinib (Ruxo, Cat: T1829), Mdivi-1 (Cat: T1907), STX-0119 (Cat: T60160),…

Lei Zhu Lei Zhu

Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer

Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia…

Zheng Li Zheng Li

Genetic alterations in thyroid cancer mediate resistance to BRAF inhibition and anaplastic transformation

This article has been reviewed according to Science X's editorial process and policies.…

02xl Admin 02xl Admin

Thyroid cancer – Symptoms and causes

Overview What is thyroid cancer? A Mayo Clinic expert explains Learn more…

02xl Admin 02xl Admin